Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1Classical hematology 1CNS 1

Conditions

beta-Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibromatosis 1 1Neoplasm, Residual 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Influenza, Human 1Hematologic Neoplasms 1Chromosome Aberrations 1Chromosome 7, monosomy 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 58fludarabine phosphate 53Mycophenolic Acid 36Whole-Body Irradiation 35Peripheral Blood Stem Cell Transplantation 35Busulfan 33Cyclosporine 32Antilymphocyte Serum 27Tacrolimus 26Melphalan 25Filgrastim 22Cord Blood Stem Cell Transplantation 21fludarabine 20Radiotherapy 20Methotrexate 16Methylprednisolone 15Thiotepa 12Etoposide 11Cytarabine 11Granulocyte Colony-Stimulating Factor 7Cyclosporins 7Rituximab 6thymoglobulin 5Sirolimus 5Leucovorin 4Bortezomib 4Bone Marrow Transplantation 4sargramostim 3merphos 3Vorinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Levetiracetam × Classical hematology × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡